Author

R. Raja

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 3 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Organism:non-human primate· 1 Approach:statistical model· 1

Frequent Co-Authors

A. C. Banerjea· 1 shared C. Wang· 1 shared C. Wu· 1 shared E. Utagawa· 1 shared K. A. Butler· 1 shared M. Curtis· 1 shared N. M. Dixit· 1 shared P. Magtibay· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. C. Banerjea

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

PP4 inhibition sensitizes ovarian cancer to NK cell-mediated cytotoxicity via STAT1 activation and inflammatory signaling

R. Raja, C. Wu, T. E. Rubino, E. Utagawa, P. Magtibay, K. A. Butler, M. Curtis

This study shows that PP4 inhibition enhances ovarian cancer sensitivity to NK cell-mediated cytotoxicity through STAT1 activation and inflammatory signaling.

bioRxiv · Aug 25, 2022Cancer Biology

HIV-1 Vif protein is stabilized by AKT-mediated phosphorylation to enhance APOBEC3G degradation

R. Raja, C. Wang, A. C. Banerjea

This study identifies AKT-mediated phosphorylation of HIV-1 Vif at T20 as a mechanism to stabilize Vif and enhance APOBEC3G degradation, revealing a complex interplay between AKT, Vif, and MDM2 in HIV-1 pathogenesis.

bioRxiv · Sep 28, 2021 · PreprintCell Biology

Early exposure to broadly neutralizing antibodies may trigger a dynamical switch from progressive disease to lasting control of SHIV infection

R. Desikan, R. Raja, N. M. Dixit

This paper models the effects of early bNAb therapy on HIV-1 infection dynamics in macaques, showing it can trigger a switch from progressive disease to lasting viremic control through pleiotropic immune effects.

bioRxiv · Jan 18, 2020Immunology